State Tipoffs Involving Missouri Newsletter for Friday February 07, 2025 ( 5 items ) |
Bryan Cave Leighton Paisner Announces Launch in Saudi Arabia
ST. LOUIS, Missouri, Feb. 7 -- Bryan Cave Leighton Paisner, a law firm, issued the following news on Feb. 6, 2025:
International law firm BCLP announces today its expansion into the Kingdom of Saudi Arabia, with plans to open offices in both Riyadh and Al-Khobar. The move is an important next step for the firm's growth strategy in the Middle East, where BCLP has been established for nearly twenty years.
Othman Alshmry and Sam Eversman will join the firm as partners to lead its operations in S
more
COLLEGE OF THE OZARKS LAUNCHES COMMUNITY EDUCATION PROGRAM
POINT LOOKOUT, Missouri, Feb. 7 -- College of the Ozarks issued the following news release:
* * *
COLLEGE OF THE OZARKS LAUNCHES COMMUNITY EDUCATION PROGRAM
College of the Ozarks, affectionately known as "Hard Work U.," is thrilled to announce the launch of its new Community Education Program, beginning in Spring 2025. This exciting initiative invites members of the community to join the College on a journey of learning, exploration, and personal enrichment. From delving into the history of t
more
From Mizzou to Arrowhead: Trevor Lerit, BJ '24, Joins the Chiefs Kingdom Behind the Scenes
COLUMBIA, Missouri, Feb. 7 -- The University of Missouri's School of Journalism issued the following news release:
* * *
From Mizzou to Arrowhead: Trevor Lerit, BJ '24, joins the Chiefs Kingdom behind the scenes
After three years on Team Truman, Trevor Lerit, BJ '24, has started a new chapter as KC Wolf's seasonal assistant, helping the Kansas City Chiefs deliver the iconic experience to fans and businesses alike.
As Truman, Lerit gained valuable experience interacting with fans of all ages
more
Nasal COVID-19 Vaccine Based on WashU Technology to Enter U.S. Clinical Trials
ST. LOUIS, Missouri, Feb. 7 -- The Washington University School of Medicine issued the following news release:
By Tamara Schneider
A nasal vaccine for COVID-19 - based on technology developed at Washington University in St. Louis - is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug application from Ocugen, Inc. was approved by the Food and Drug Administration (FDA). Ocugen, a U.S.-based biotechnology company, licensed the innovative technology from WashU
more
New Emerson Pressure Relief Valve Optimizes Safety and Performance in Critical Gas Applications
ST. LOUIS, Missouri, Feb. 7 -- Emerson, a technology, software and engineering company that says it provides solutions for customers in industrial, commercial and residential markets, issued the following news release:
* * *
New Emerson Pressure Relief Valve Optimizes Safety and Performance in Critical Gas Applications
Anderson Greenwood Type 84 valves deliver leak-tight service at very high pressures for hydrogen storage, transport and refueling stations
STAFFORD, Texas (Feb. 6, 2025) - Eme
more
|
Sign up to Receive this newsletter every day via email.